SiteOne Therapeutics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2010-01-01
- Employees
- 1
- Market Cap
- -
Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ST-2427
- First Posted Date
- 2020-07-17
- Last Posted Date
- 2023-08-03
- Lead Sponsor
- SiteOne Therapeutics, Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT04475198
- Locations
- 🇺🇸
Altasciences, Overland Park, Kansas, United States
News
No news found